πŸ‡ΊπŸ‡Έ FDA
Patent

US 7662408

Sustained-release preparations

granted A61KA61K38/08A61K38/24

Quick answer

US patent 7662408 (Sustained-release preparations) held by Takeda Pharmaceutical Company Limited expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/08, A61K38/24, A61K47/34, A61K9/5031